Liver diseases - 4 News by HepaRegeniX from Germany

Liver diseases - 4 News by HepaRegeniX from Germany

image description

HepaRegeniX appoints Dr. Martin Bonde as new Chair of the Board

Preparations for upcoming clinical trials in the USA are ongoing

23-Oct-2024 - HepaRegeniX GmbH, a clinical stage company developing a novel regenerative therapy for the treatment of acute and chronic liver diseases, announced the appointment of Dr. Martin Bonde as its new Chair of the Board of Directors, effective immediately. His appointment follows the recent €15 million ...

liver diseases personnel changes phase II studies
image description

HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration

Elias Papatheodorou moves from Chair of the Board to CEO of HepaRegeniX

15-Jul-2024 - HepaRegeniX GmbH, a clinical stage company developing novel regenerative therapies for the treatment of acute and chronic liver diseases, announced the closing of a Series C round led by Vesalius Biocapital IV with participation of existing investors Novo Holdings, Boehringer Ingelheim Venture ...

liver diseases liver liver cancer
image description

Start-up raises hope in the fight against acute and chronic liver diseases

The biotech company HepaRegeniX, founded in 2017, starts clinical testing of the tolerability of its developed drug in volunteers.

11-Aug-2021 - The Tübingen-based start-up HepaRegeniX recently began a Phase I clinical trial to test the tolerability of a novel drug against liver disease in healthy volunteers. The drug is a so-called MKK4 inhibitor, which, when administered, curbs the activity of the kinase MKK4. Preclinical studies have ...

liver diseases drug design liver
image description

€11 Mio. for the treatment of acute and chronic liver diseases

HepaRegeniX secures Series B Financing

23-Jan-2020 - Preclinical data demonstrate efficacy of MKK4 inhibitors in liver regeneration and experimental acute and chronic liver disease models. HepaRegeniX GmbH, a preclinical stage company developing a novel therapy for the treatment of acute and chronic liver diseases announced the closing of its ...

liver diseases Series B financing
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 0 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now